TCR2 THERAPEUTICS INC. Annual Nonoperating Income (Expense) in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Tcr2 Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2022.
  • Tcr2 Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2023 was $1.11M, a 850% increase year-over-year.
  • Tcr2 Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was $2.93M, a 1203% increase year-over-year.
  • Tcr2 Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $1.94M, a 765% increase from 2021.
  • Tcr2 Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $224K, a 87.1% decline from 2020.
  • Tcr2 Therapeutics Inc. annual Nonoperating Income (Expense) for 2020 was $1.74M, a 55.3% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.94M +$1.71M +765% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 $224K -$1.51M -87.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $1.74M -$2.15M -55.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $3.89M +$1.68M +76.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $2.2M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.